News

A National Cancer Institute trial conducted through the Gynecologic Oncology Group points to an effective way to improve outcomes for women with advanced ovarian cancer. Researchers at the Stephenson Cancer Center at the University of Oklahoma Health Sciences Center enrolled more patients in this pivotal trial than any other site in the world. Robert Mannel, MD, director of the Stephenson Cancer Center and a gynecologic oncologist, is a co-author of the landmark manuscript appearing in the New England Journal of Medicine.

Read more >

The Stephenson Cancer Center welcomes new Oklahoma TSET Research Scholar and clinical psychologist Ted Wagener, PhD. Wagener comes to Oklahoma from the Alpert Medical School of Brown University, where he completed his predoctoral internship and postdoctoral fellowship. He received his doctorate in clinical psychology with an emphasis in behavioral medicine from Oklahoma State University.

Read more >

Three Oklahoma researchers have been awarded $160,000 in seed grants by the Oklahoma Tobacco Research Center of the Stephenson Cancer Center. The funding will advance research into tobacco cessation, as well as lung cancer screening and treatment. This year's recipients include one researcher from each of these three institutions: OU Norman, OU Health Sciences Center, and the University of Tulsa.

Read more >

The Stephenson Cancer Center is bringing a promising new investigational drug to Oklahoma patients faced with a potentially deadly form of skin cancer. The Stephenson Cancer Center is the first and only institution in Oklahoma to offer the investigational drug vemurafenib as part of an “expanded access” clinical trial. The clinical trial is enrolling patients in this state with a common form of metastatic melanoma, the deadliest form of skin cancer.

Read more >

An Oklahoma scientist studying the role of protein interaction in the formation of prostate cancer has been awarded a $1.5 million research grant by the National Cancer Institute to further his work for the next five years. Ralf Janknecht, PhD, the director of the Basic Cancer Biology Program at the Stephenson Cancer Center, was awarded the grant after a rigorous competitive review of his project.

Read more >
12